Search Results 11-20 of 16136 for immunothérapie Bylaska

  1. Immunotherapy Clinical Trials - Mayo Clinic Research

    Immunotherapy. Displaying 22 studies. Immunotherapeutic Strategy to Treat Recurrent Respiratory Papillomatosis Scottsdale/Phoenix, AZ. The purpose of this ...

  2. New Immunotherapy Approved for Metastatic Bladder Cancer - Mayo Clinic News Network

    Patients with metastatic bladder cancer have few treatment options after failure of chemotherapy until now. In early May, the U.S. Food and Drug Administration ...

  3. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

    A new study explores the combination of the intratumoral administration of the measles virus with systemic PD-L1 targeted immunotherapy using atezolizumab ...

  4. Immunotherapy Of Vestibular Function Impact - Mayo Clinic

    The purpose of this study is to determine if immunotherapy checkpoint inhibitors influence vestibular function. Participation eligibility. Participant ...

  5. Biological therapy for cancer - Care at Mayo Clinic

    Immunotherapy side effects. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects. Accessed Feb. 10 ...

  6. Biological Therapy For Cancer Clinical Trials - Mayo Clinic Research

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  7. An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer - Mayo Clinic

    An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove ...

  8. Phase IIB/III of TG4010 Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    TG4010 has been developed for use as an immunotherapy in cancer patients whose tumors express the MUC1 antigen. TG4010 is intended to induce a MUC1-specific ...

  9. Tumor Immunology and Immunotherapy - Department of Cancer Biology - Mayo Clinic Research

    The Department of Cancer Biology at Mayo Clinic is developing strategies to stimulate the immune system to target cancer cells for tumor regression and ...

  10. Myeloid Cell Interactions Modulate Combination Immunotherapy Outcomes in the Liver Tumor Microenvironment - Mayo Clinic Research

    This proposal in the Career Enhancement Program of the Mayo Clinic Hepatobiliary SPORE studies research models of cancer and immune cells interacting during ...